- Home
- GPRK vs FDMT Comparison
GPRK vs FDMT Comparison
Compare GPRK & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- FDMT
- Stock Information
- Founded
- GPRK 2002
- FDMT 2013
- Country
- GPRK Colombia
- FDMT United States
- Employees
- GPRK N/A
- FDMT N/A
- Industry
- GPRK Oil & Gas Production
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- GPRK Energy
- FDMT Health Care
- Exchange
- GPRK Nasdaq
- FDMT Nasdaq
- Market Cap
- GPRK 408.5M
- FDMT 420.7M
- IPO Year
- GPRK N/A
- FDMT 2020
- Fundamental
- Price
- GPRK $9.15
- FDMT $6.31
- Analyst Decision
- GPRK Strong Buy
- FDMT Buy
- Analyst Count
- GPRK 2
- FDMT 11
- Target Price
- GPRK $12.50
- FDMT $42.80
- AVG Volume (30 Days)
- GPRK 826.4K
- FDMT 1.0M
- Earning Date
- GPRK 11-06-2024
- FDMT 11-13-2024
- Dividend Yield
- GPRK 6.43%
- FDMT N/A
- EPS Growth
- GPRK N/A
- FDMT N/A
- EPS
- GPRK 1.97
- FDMT N/A
- Revenue
- GPRK $716,838,000.00
- FDMT $17,000.00
- Revenue This Year
- GPRK N/A
- FDMT N/A
- Revenue Next Year
- GPRK $22.01
- FDMT $87.55
- P/E Ratio
- GPRK $4.65
- FDMT N/A
- Revenue Growth
- GPRK N/A
- FDMT N/A
- 52 Week Low
- GPRK $7.24
- FDMT $5.58
- 52 Week High
- GPRK $11.72
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- GPRK 42.06
- FDMT 36.69
- Support Level
- GPRK $10.66
- FDMT $5.58
- Resistance Level
- GPRK $11.45
- FDMT $7.58
- Average True Range (ATR)
- GPRK 0.53
- FDMT 0.46
- MACD
- GPRK -0.25
- FDMT -0.06
- Stochastic Oscillator
- GPRK 2.83
- FDMT 34.93
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil and Argentina. The company generates revenue from the sale of crude oil, condensate and natural gas net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.